Dyslipidemia and asthma level control in children at national hospital in Lima, 2022-2023

Espinoza L.Z.; Gutiérrez Ó.G.H.; Guerra H.G.; Lázaro J.M.P. · Nutricion Hospitalaria (2026) · DOI: 10.20960/nh.05928

Resumen

Introduction: bronchial asthma is a disease with a high prevalence in childhood; understanding the relationship with another chronic disease like adiposity or dyslipidemia can contribute to control and improve quality of life in these patients. Objective: to find the relationship between dyslipidemia and asthma control level in children at a National Hospital in Lima, Peru. Material and methods: a transversal, cross association, descriptive study. The population included children aged 5 to 11 years who consulted for asthma control between October 2022 and October 2023 (n = 74). Blood values of glucose, total cholesterol (CT), triglycerides (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL) and TG/HDL ratio were quantified in 8-hour fasting venous blood. Pediatric asthma control level (ACL) was categorized by c-ACT 5. Pearson’s correlation test was applied for CT and ACL, and Spearman’s correlation test for other lipid variables and ACL Results: dyslipidemia prevalence was 58 %. We found moderate correlation between HDL and c-ACT 5 score (rS = 0.5, p = 0.00). We found no significative relation between CT and ACL (rP = 0.19, p = 0.06). Conclusion: there is a significative relation between HDL and asthma control level.

Instituciones: Universidad Nacional Mayor de San Marcos